Rocky Mountain IBD Course 2022

Please visit www.rockymountainibd.com for more information and to register for the 2022 Rocky Mountain IBD course in Jackson, WY.

AGENDA

Join us March 11-13, 2022 for informative educational sessions and networking with colleagues.

The preliminary 2022 RMIBD Conference Agenda* is as follows

Friday, March 11

  • 6:00-7:30 pm Registration & Welcome Reception

Saturday, March 12

  • 6:30-6:55 am Registration & Breakfast w/ Faculty: Posters & Exhibits
  • 6:55-7:00 am Opening Remarks
  • 7:00-7:30 am Social Determinants of Health and Healthcare Disparities in IBD
    • Ann Flynn, MD; University of Utah
  • 7:30-8:00 am A Pharmacist's Recommendations for Getting Your Patients What You Think They Need
    • Jennifer Aoto, PharmD; University of Colorado Health
  • 8:00-8:30 am Treat-to-Target: What's the Target?
    • Jessica Johnson, MD; University of Utah
  • 8:30-9:00 am Histology as a Treatment Target-Are We There Yet?
    • David Rubin, MD; University of Chicago
  • 9:00-9:30 am Safety of IMD Medications during Conception & Pregnancy for Men and Women with IBD
    • Uma Mahadevan, MD; University of California San Francisco
  • 9:30-10:00 am Questions to the Panel
  • 10:00 am-4:00 pm BREAK
  • 4:00-4:30 pm Positioning Medications in UC and Crohn's Disease
    • David Rubin, MD; University of Chicago
  • 4:30-5:00 pm Incorporating Therapeutic Drug Monitoring into Clinical Practice
    • Frank Scott, MD; University of Colorado Anschutz Medical Campus
  • 5:00-5:30 pm Dual Biologic or Small Molecule Therapy for the Treatment of IBD
    • Waseem Ahmed, MD; University of Colorado Anschutz Medical Campus
  • 5:30-6:00 pm Emerging IBD Therapies
    • Uma Mahadevan, MD; University of California San Francisco
  • 6:00-6:15 pm Questions to the Panel
  • 6:15-6:45 pm Case Presentation & Audience Discussion
  • 6:45 pm ADJOURN

Sunday, March 13

  • 6:30-6:55 am Registration & Breakfast w/ Faculty: Posters & Exhibits
  • 6:55-7:00 am Opening Remarks
  • 7:00-7:30 am Post-operative Management of Crohn's Disease
    • Ben Click, MD; University of Colorado Anschutz Medical Campus
  • 7:30-8:00 am Withdrawal and De-escalation of IBD Treatment
    • 'Amir Kashani, MD; University of Utah
  • 8:00-8:30 am GI Complications of Immune-Mediated Therapy
    • Debbie Cheng, MD; University of Colorado Anschutz Medical Campus
  • 8:30-9:00 am IBD Year in Review
    • John Valentine, MD; University of Utah
  • 9:00-9:15 am Questions to the Panel
  • 9:15-9:45 am Case Presentation & Audience Discussion
  • 9:45-10:00 am Closing Remarks
  • 10:00 am ADJOURN

*Subject to change

The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All attendees are encouraged to use the CME system to claim their attendance. Physicians will be awarded AMA PRA Category 1 credits TM; all other professions will be awarded attendance at a CME event credit that they may use for their re-credentialing purposes. Nurses seeking contact hours must claim through the CME system. All users will be able to print or save certificates. For questions regarding the CME system, please contact the UUCME Office. For questions regarding re-credentialing process or requirements, please contact your re-credentialing organization.

ABIM MOC Medical Knowledge Assessment Part II Credit: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

Course Coordinator

Lynsey Bell

Click here to email.